These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8262674)

  • 1. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
    Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
    Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
    Niikura H; Sasano H; Kaga K; Sato S; Yajima A
    Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
    Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
    Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
    Scambia G; Benedetti-Panici P; Ferrandina G; Distefano M; Salerno G; Romanini ME; Fagotti A; Mancuso S
    Br J Cancer; 1995 Aug; 72(2):361-6. PubMed ID: 7640219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
    Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
    Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma.
    Niikura H; Sasano H; Matsunaga G; Watanabe K; Ito K; Sato S; Yajima A
    Hum Pathol; 1995 Aug; 26(8):892-6. PubMed ID: 7635451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
    Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
    J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
    Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
    Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium.
    Athanassiadou P; Petrakakou E; Liossi A; Nakopoulou L; Zerva C; Dimopoulos A; Athanassiades P
    Acta Cytol; 1999; 43(6):1039-44. PubMed ID: 10578976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of hormone receptors in endometrial cancer.
    Creasman WT
    Cancer; 1993 Feb; 71(4 Suppl):1467-70. PubMed ID: 8431882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic value of EGFR in invasive breast cancer.
    Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
    Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
    Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
    Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones.
    Gershtein ES; Shatskaya VA; Kostyleva OI; Ermilova VD; Kushlinsky NE; Krasil'nikov MA
    Cancer; 1995 Dec; 76(12):2524-9. PubMed ID: 8625080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N
    Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
    Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
    Lukes AS; Kohler MF; Pieper CF; Kerns BJ; Bentley R; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC; Berchuck A
    Cancer; 1994 May; 73(9):2380-5. PubMed ID: 7909491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
    Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
    Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.